Form 4 for TMDX TransMedics Group, Inc.
Accepted 2021-09-01 00:00:00 ET · period of report 2021-08-30 · accession 0000899243-21-034767 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-01 | 2021-08-30 | TMDX | Sullivan John F | VP of Quality, Engineering | M - OptEx | $0.28 | +3,200 | 14.3K | +29% | +$896.00 |
| D | 2021-09-01 | 2021-08-30 | TMDX | Sullivan John F | VP of Quality, Engineering | M - OptEx | $0.00 | -3,200 | 15.8K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | M | A | 3,200 | $0.28 | 14,273 | D | — | — | (F1) Includes 245 shares acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-08-30 | M | D | 3,200 | $0.00 | 15,772 | D | $0.28 · — to 2023-05-29 | 3,200 Common Stock | (F2) The option is fully vested. |